Home > Products > Accessories >

AlbuVoid Buffer Kit™



 
Price: $350.00


Product Code: AVBK


Size (AVBK):
  

Qty:
Description Applications Specifications
 

AlbuVoid Binding Buffer AVBB™

  1. Ready to use, pre-filter with 0.2 um filter
  2. PH 6.0
  3. Optimized for albumin voiding.
  4. Mild binding condition preserves the enzymatic and biological activity.

AlbuVoid Wash Buffer AVWB™

  1. Ready to use, pre-filter with 0.2 um filter
  2. PH 7.0

AlbuVoid Elution Buffer AVEB™

  1. Ready to use, pre-filter with 0.2 um filter
  2. PH 9.8 to 10
  3. Mild elution maintains tertiary structure and simple transfer to secondary analysis. The eluted fractions retain their enzymatic and biological activity.
Click Here For AlbuVoid™ Product Sheet.
Click Here For AlbuVoid™ On Bead Digestion Protocol
References

Serum

Grubbs, J. K., et al. "Investigation of the efficacy of albumin removal procedures on porcine serum proteome profile1." (2015).

Discovery of Functional Serum Biomarkers Using AlbuVoid™ Enrichment and the ArrayBridge PEP Profiling Platform.Personal communication, Xing Wang, Ph.D., ArrayBridge (St. Louis, MO), manuscripts in process.

Serum Profiling Making Mark on Predictive Medicine
Vicki Glaser.Genetic Engineering & Biotechnology News. 2011;31(7):1-55.

Kuruc Matt. Application Report - AlbuVoid™ & On-Bead Digestion - Tackling the challenges of serum proteomics (LC-MS).

Kuruc Matt, Dr.Roy. Application Report -AlbuVoid™ LC-MS On-Bead – Differential Expression of Cancer Sera Proteins Using Quantitative (iTRAQ) Proteomics

Plasma
Espes, Daniel, Joey Lau, and Per-Ola Carlsson. "Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes." Diabetologia(2013): 1-4.

Patent - Secretome Sample Preparation
Narain, Niven Rajin, and Paula Patricia Narain. "COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER." U.S. Patent No. 20,150,023,949. 22 Jan. 2015.

Narain, Niven Rajin, Rangaprasad Sarangarajan, and Vivek K. Vishnudas. "INTERROGATORY CELL-BASED ASSAYS AND USES THEREOF." U.S. Patent No. 20,120,258,874. 11 Oct. 2012.

Cell Culture
Narain, Niven Rajin, Rangaprasad Sarangarajan, Vivek K. Vishnudas, and Michael Andrew Kiebish. "USE OF MARKERS IN THE IDENTIFICATION OF CARDIOTOXIC AGENTS AND IN THE DIAGNOSIS AND MONITORING OF CARDIOMYOPATHY AND CARDIOVASCULAR DISEASE." U.S. Patent 20,140,100,128, issued April 10, 2014.

On-Bead Digestion Protocols For LC-MS Proteomic Workflows
New on-bead digestion for LC-MS applications for proteomic studies

US HUPO 2014. Frontiers in Proteomics: Advancing Biology through Technology and Computation.
AlbuVoid™ abstract entitled "Improved proteomic enrichment and workflow strategies", poster board 089 presented at US HUPO 2014